Comparative Pharmacology
Head-to-head clinical analysis: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN versus WESTADONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN versus WESTADONE.
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN vs WESTADONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Tramadol is a centrally acting synthetic opioid analgesic that binds to μ-opioid receptors and inhibits serotonin and norepinephrine reuptake. Acetaminophen inhibits cyclooxygenase (COX) enzymes in the central nervous system, reducing prostaglandin synthesis.
Mu-opioid receptor agonist; also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake.
Adults: 1-2 tablets (37.5-75 mg tramadol / 325-650 mg acetaminophen) orally every 4-6 hours as needed for pain; maximum 8 tablets/day (300 mg tramadol / 2600 mg acetaminophen).
Oral: 2.5-10 mg every 4-6 hours as needed for pain; maximum 40 mg per day.
None Documented
None Documented
Tramadol has a terminal elimination half-life of approximately 5–6 hours; for its active metabolite O-desmethyltramadol (M1), the half-life is about 7–9 hours. Acetaminophen has a half-life of 2–3 hours. These values are prolonged in hepatic or renal impairment and in elderly patients.
Terminal elimination half-life: 15-60 hours (mean ~24 hours). Clinical context: Prolonged half-life supports once-daily dosing in opioid maintenance; accumulation occurs with repeated dosing due to long half-life.
Tramadol and its metabolites are primarily excreted renally (approximately 90% of total clearance), with about 30% excreted as unchanged drug and the remainder as metabolites. Fecal excretion accounts for less than 10%. Acetaminophen is primarily metabolized by the liver and excreted renally as glucuronide and sulfate conjugates; about 2-5% is excreted unchanged. Renal clearance of tramadol is reduced in renal impairment.
Primarily renal (40-50% as unchanged methadone and its metabolites, 15-20% as metadone-N-oxide), biliary/fecal (5-10%).
Category D/X
Category C
Opioid Agonist
Opioid Agonist